Metastases to liver – Diagnostics

Go back

Diagnosing liver metastases involves understanding whether cancer from another part of your body has spread to your liver. This process combines careful attention to symptoms, physical examinations, blood tests, and imaging techniques that help doctors see what’s happening inside your body. Because liver metastases are far more common than cancers that start in the liver itself, getting an accurate diagnosis is essential for planning the right treatment and understanding what lies ahead.

Introduction: When to Seek Diagnostic Testing

If you have been diagnosed with cancer in another part of your body, or if you’ve had cancer in the past, your doctor may recommend regular checks to see if the disease has spread to your liver. The liver is one of the most common places where cancer travels, because it filters enormous amounts of blood every day—more than 250 gallons pass through it daily. This steady flow of blood means that cancer cells from other organs can easily reach the liver through the bloodstream or through the vessels that carry lymph, a fluid that circulates throughout your body to help fight infections.[1][6]

You should seek diagnostic testing if you notice new or worsening symptoms, especially if you have a history of cancer. Common warning signs include losing weight without trying, feeling unusually tired or weak, losing your appetite, or experiencing discomfort in the upper right side of your belly where your liver sits. Some people notice yellowing of their skin and the whites of their eyes, a condition called jaundice, along with dark-colored urine or pale stools. Swelling in the abdomen or ankles, itching, nausea, fever, or persistent pain can also be red flags.[1][5][6]

It’s important to understand that liver metastases may not cause symptoms right away. Because the liver is large and can continue working even when cancer is present, you might feel perfectly fine in the early stages. That’s why people who have been treated for colorectal, lung, breast, pancreatic, stomach, esophageal, or certain other cancers often have regular follow-up appointments and imaging tests, even if they feel well. Early detection through routine screening gives doctors the best chance to act quickly and choose the most effective treatments.[1][3]

⚠️ Important
Many symptoms of liver metastases, such as fatigue, weight loss, and belly discomfort, can also be caused by other health problems. If you notice these symptoms, especially if they are getting worse, see your doctor right away. Early medical attention can help determine the cause and guide you toward the right care.

Classic Diagnostic Methods

Health History and Physical Examination

The first step in diagnosing liver metastases is a thorough conversation with your doctor. Your healthcare provider will ask about your symptoms, including when they started and how they’ve changed over time. They will also want to know about your medical history, particularly if you’ve had cancer before or if you have risk factors such as chronic liver disease. This detailed health history helps your doctor understand what might be happening inside your body and which tests to order next.[1][15]

During the physical exam, your doctor will carefully examine your abdomen. They will gently press on the area where your liver is located, beneath your right ribcage, to check if it feels larger than normal or tender to the touch. An enlarged liver, known as hepatomegaly, can be a sign that cancer has spread there. Your doctor may also look for other physical signs, such as yellowing of your skin or eyes, swelling in your belly from fluid buildup called ascites, or swelling in your ankles.[1][4][6]

Blood Tests

Blood tests play a crucial role in diagnosing liver metastases. These tests measure levels of different chemicals and proteins in your blood to see how well your organs are working and to look for signs of disease. One of the most common blood tests is called a liver function test. This test checks for enzymes and other substances produced by the liver, such as alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (GGT). When these levels are higher than normal, it may indicate liver damage or disease, including metastases.[1][4]

Your doctor may also order a complete blood count (CBC), which checks your overall health and how well your bone marrow is producing blood cells. Blood glucose (sugar) and blood clotting tests might be done to check for liver damage caused by metastases. These tests help your healthcare team understand how your liver is functioning and whether it has been affected by cancer.[1]

Another important type of blood test is a tumor marker test. Tumor markers are specific proteins that can be measured in your blood. If you had cancer in the past, such as colorectal cancer, your doctor might measure a marker called carcinoembryonic antigen (CEA). Rising levels of CEA over time could suggest that the cancer has returned and spread to the liver. Sometimes, tissue samples taken during a biopsy are also tested for tumor markers to help identify what type of cancer has spread to the liver.[1][15]

Imaging Tests

Imaging tests are essential for diagnosing liver metastases because they allow doctors to see inside your body without surgery. It is common to have one or more imaging tests when liver metastases are suspected. These tests create detailed pictures of your liver and can show the number, size, and location of any tumors.[1][4]

Ultrasound is often one of the first imaging tests used. It uses sound waves to create real-time images of your liver and other organs. Ultrasound is non-invasive, painless, and doesn’t involve radiation. A special type called pelvic ultrasound or transvaginal ultrasound may be used if your doctor wants to look at organs near your liver.[1][6]

CT scans (computed tomography scans) are commonly used to evaluate liver metastases. A CT scan uses X-rays and a computer to create detailed, three-dimensional images of your body. Often, you may have a triple-phase CT scan, which takes images at different times after a contrast dye is injected into your bloodstream. This helps doctors see blood flow in the liver and detect tumors more clearly.[4][6]

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues like the liver. MRI is particularly good at showing the characteristics of liver tumors and can help doctors tell the difference between different types of growths. MRI scans may be recommended if the CT scan results are unclear or if more detailed images are needed.[4][6]

PET scans (positron emission tomography) involve injecting a small amount of radioactive sugar into your body. Cancer cells absorb more sugar than normal cells, so they show up brighter on the scan. PET scans are often combined with CT scans to provide both detailed pictures and information about how active the cancer cells are. This can help doctors see if cancer has spread beyond the liver to other parts of your body.[6]

Liver Biopsy

A liver biopsy is a procedure where a small sample of liver tissue is removed so it can be examined under a microscope. This test helps doctors confirm whether cancer is present in the liver and identify what type of cancer it is. For example, if you had breast cancer years ago and now have a suspicious spot on your liver, a biopsy can show whether the cells in your liver are breast cancer cells that have spread, or if it’s a different kind of problem.[4][6]

There are different ways to perform a liver biopsy. The most common method is a core needle biopsy, where a thin needle is inserted through your skin and into your liver to collect a small tissue sample. This is usually done with the help of ultrasound or CT imaging to guide the needle to the right spot. A medical specialist called a pathologist will then examine the tissue sample to identify the cancer cells and determine their origin. This information is critical for planning your treatment.[4]

Diagnostics for Clinical Trial Qualification

When patients with liver metastases are being considered for participation in a clinical trial, additional diagnostic tests are often required. Clinical trials are research studies that test new treatments or combinations of treatments to see if they work better than current options. These trials have strict rules, called eligibility criteria, to make sure that only patients who are likely to benefit and who can safely participate are enrolled.

To qualify for a clinical trial, you will typically need to undergo the same standard diagnostic tests mentioned earlier—such as blood tests, imaging scans (CT, MRI, PET), and possibly a liver biopsy—to confirm the presence and extent of liver metastases. However, clinical trials often require more detailed or additional testing to gather specific information about your cancer. For example, researchers may want to know the exact genetic makeup of your tumor, so they might test your biopsy sample for specific genetic mutations or proteins that could respond to the treatment being studied.[3]

Your overall health will also be carefully assessed. Blood tests will check your liver function, kidney function, and blood cell counts to ensure your body can handle the trial treatment. Imaging tests will measure the size and number of tumors in your liver and check whether cancer has spread to other organs. Doctors will also evaluate your general physical condition, often using a scale that measures how well you can carry out daily activities. This helps them understand if you’re strong enough to tolerate the experimental treatment.[3]

It’s important to remember that qualifying for a clinical trial doesn’t mean your condition is worse or better than others—it simply means your specific situation matches what the researchers are studying. Clinical trials offer access to new treatments that may not yet be available to the general public, but they also come with unknowns, such as possible side effects or uncertain effectiveness. Your healthcare team will explain all the tests required, the goals of the trial, and what participation would involve, so you can make an informed decision.

⚠️ Important
Participating in a clinical trial is entirely voluntary. You have the right to ask questions, take your time deciding, and change your mind at any time. Your healthcare team is there to support you and provide all the information you need to feel confident in your choices.

Prognosis and Survival Rate

Prognosis

The outlook for people with liver metastases depends on several factors. One of the most important is where the cancer originally started. For example, colorectal cancer that has spread to the liver can sometimes be treated with surgery or other therapies that offer a chance of long-term survival. In fact, nearly 70 to 80 percent of people with metastatic colorectal cancer have disease confined to the liver, and surgery can lead to five-year survival rates of up to 40 percent in selected patients.[3][12]

Other factors that affect prognosis include the number and size of tumors in the liver, whether cancer has spread to other parts of the body beyond the liver, your overall health, and how well your liver is functioning. People who have cancer in only one area of the liver and no cancer elsewhere in the body generally have better outcomes than those with cancer in multiple spots or in several organs. Your response to treatment also plays a major role—some people respond very well to chemotherapy, targeted drugs, or other therapies, which can slow or stop the cancer’s growth.[3][6][22]

It’s important to remember that every person’s situation is unique. While statistics can give a general idea of what to expect, they cannot predict exactly what will happen in your case. Advances in medicine, including new treatments and combinations of therapies, are improving outcomes for many patients. Your healthcare team will work with you to create a treatment plan tailored to your specific needs and goals.

Survival Rate

Survival rates for liver metastases vary widely depending on the type of primary cancer and how far the disease has spread. For example, the relative five-year survival rate for liver cancer that has spread to nearby lymph nodes or tissues is around 11 percent, according to data from large groups of patients in the United States.[22]

For people with metastatic colorectal cancer that has spread to the liver, survival outcomes depend on whether the cancer can be surgically removed. When surgery is possible, five-year survival rates can reach 40 percent. However, only about 25 percent of patients with colorectal liver metastases are candidates for surgery at the time of diagnosis. For those who cannot have surgery, other treatments such as chemotherapy, targeted therapy, or regional therapies like radiofrequency ablation can help control the disease and extend life.[3][12]

In one small study of people with metastatic liver cancer that had spread to lymph nodes or distant organs, average survival ranged from 4 to 11 months, depending on the severity of liver damage and whether treatment was received.[22] These numbers highlight the importance of early detection, timely treatment, and ongoing medical care.

It’s also worth noting that survival statistics are based on large groups of people and reflect outcomes from past years. New treatments are constantly being developed, and many patients today are living longer and with better quality of life than was possible even a few years ago. Your doctor can provide more personalized information based on your specific diagnosis and health status.

Ongoing Clinical Trials on Metastases to liver

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    France
  • Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France
  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Recruiting

    3 1 1 1
    The Netherlands
  • Study on Preoperative Immunotherapy with Atezolizumab and Tiragolumab for Patients with Colorectal Liver Metastases

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Norway

References

https://cancer.ca/en/cancer-information/cancer-types/metastatic/liver-metastases

https://www.mskcc.org/cancer-care/types/liver-metastases

https://www.ncbi.nlm.nih.gov/books/NBK553118/

https://en.wikipedia.org/wiki/Liver_metastasis

https://www.healthline.com/health/liver-metastases

https://my.clevelandclinic.org/health/diseases/metastatic-liver-cancer

https://www.mskcc.org/cancer-care/types/liver-metastases/treatment

https://www.cancer.org/cancer/supportive-care/advanced-cancer/liver-metastases.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC8479345/

https://www.cancerresearchuk.org/about-cancer/secondary-cancer/secondary-liver-cancer/treatment

https://hpbsurgery.ucsf.edu/condition/liver-metastases

https://pmc.ncbi.nlm.nih.gov/articles/PMC4611310/

https://surgery.ucsf.edu/condition/liver-metastases

https://nyulangone.org/conditions/liver-cancer-liver-metastases/treatments/targeted-therapies-for-liver-cancer-liver-metastases

https://cancer.ca/en/cancer-information/cancer-types/metastatic/liver-metastases

https://pmc.ncbi.nlm.nih.gov/articles/PMC5701682/

https://cancer.ca/en/cancer-information/cancer-types/metastatic/liver-metastases

https://www.cancer.org/cancer/supportive-care/advanced-cancer/liver-metastases.html

https://www.cancerresearchuk.org/about-cancer/secondary-cancer/secondary-liver-cancer/treatment

https://www.kolhapurcancercentre.com/blog/can-you-survive-metastatic-liver-cancer/

https://www.mskcc.org/cancer-care/types/liver-metastases/treatment/follow

https://www.healthline.com/health/cancer/stages-of-metastatic-liver-cancer

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What is the difference between primary liver cancer and liver metastases?

Primary liver cancer starts in the liver itself, while liver metastases occur when cancer from another part of the body spreads to the liver. The cancer cells found in liver metastases are not liver cells—they are cells from the organ where the cancer originally started, such as the colon, breast, or lungs.[1][4]

Can liver metastases be cured?

In some cases, yes. For certain types of cancer, such as colorectal cancer, surgery to remove liver metastases can offer a chance of cure, with five-year survival rates reaching up to 40 percent in carefully selected patients. However, for many people, the goal of treatment is to control the cancer, relieve symptoms, and prolong life rather than to cure it completely.[3][12]

Why does cancer spread to the liver so often?

The liver filters more than 250 gallons of blood every day, and it receives blood from two sources: the hepatic artery and the portal vein. This rich blood supply means that cancer cells traveling through the bloodstream or lymphatic system are more likely to reach and settle in the liver.[3][6]

What imaging test is best for detecting liver metastases?

CT scans and MRI scans are the most commonly used imaging tests for diagnosing liver metastases. A triple-phase CT scan, which takes images at different times after injecting contrast dye, is particularly effective at showing tumors. MRI provides excellent detail of soft tissues and can help distinguish between different types of liver growths.[4][6]

Do I need a liver biopsy to diagnose liver metastases?

Not always. In many cases, imaging tests combined with your medical history and blood tests can provide enough information to diagnose liver metastases. However, if your doctor needs to confirm the diagnosis or identify the type of cancer, a liver biopsy may be recommended. The biopsy involves taking a small sample of liver tissue for examination under a microscope.[4][6]

🎯 Key Takeaways

  • Liver metastases are cancer cells that have spread to the liver from another part of the body and are far more common than cancers that start in the liver itself.
  • Early symptoms may be mild or absent, but as the disease progresses, warning signs like weight loss, fatigue, jaundice, and abdominal pain can appear.
  • Diagnosing liver metastases involves a combination of health history, physical examination, blood tests, imaging scans (ultrasound, CT, MRI, PET), and sometimes a liver biopsy.
  • The liver’s unique dual blood supply makes it especially vulnerable to cancer spreading from other organs, particularly the digestive system.
  • Tumor marker tests, such as CEA for colorectal cancer, can help detect cancer recurrence and spread to the liver.
  • Clinical trials may require additional or more detailed diagnostic tests to ensure patients meet specific eligibility criteria.
  • Prognosis and survival depend on factors like the type of primary cancer, number and size of liver tumors, overall health, and response to treatment.
  • For selected patients with colorectal liver metastases, surgical removal can lead to five-year survival rates of up to 40 percent, but only about 25 percent are candidates for surgery at diagnosis.